There is a widespread belief among clinicians that trifluoperazine (Tr) is more effective than chiorpromazine (Ch) in activating retarded schizo
phrenic patients. We examined the effect of these two drugs on the motor activity of three groups of inactive patients : A, very inactive; B, moderately inactive and C, mildly inactive. All these patients were under 6o, with at least io years duration of illness.
We excluded those with subnormality or physical illness and those who had a leucotomy.
They were all sufficiently inactive to fall below the mid-point on the Venables scale (Venables, 1957) , so that an increase in activity constituted an improve ment. The same supervisors and raters were used throughout and attempts were made to maintain the work environment as constant as possible. The raters did not have access to their earlier scores.
Motor performance was measured : (i ) by assessing quantity and quality of work at a factory type of task; (2) by use of the Venables activity-withdrawal scale (Venables, 1957 J. ment. Sci., 103, 197) , before the experiment and at the end of each phase. The patients worked in three groups of i @, with the same supervisor throughout : initial placebo period of six months, â€˜¿ 0 patients placebo (P1), 2 Ch; phase i, six weeks, 6 Ch 6 Tr; phase 2, six weeks, 12 P1; phase 3, six weeks, 6 Tr 6 Ch. Before the initial placebo period, the level of treatment with Ch or Tr considered optimal, ranged from 200 mgm. to 6oo mgm. Ch and from 20 mgm.
to 6o mgm. Tr per day. During the experiment these â€˜¿ optimal' dosages were used. Drugs and placebo were identical in appearance. The patients were not told when changes in medication were being made.
RESULTS
Performance at the factory task has been analysed in terms of (a) the weighted mean task error, that is, the ratio of the total error per minute to the total number of pieces produced, giving a general measure of performance; (b) the total quantity produced in unit time, giving a measure of the speed of work; (c) the mean error giving a measure of the accuracy ofwork.The effect ofdrugswas examinedby analysis of covariance within groups. Statistical data can be made available on request to the authors.
(a) Weightedmean task error. Significant differences between drugs were found in two instances, half of groups B and C (the more active groups) but the direction differed in the two groups, the drug which was given first was significantly better than the other (p < o @ 0 I and p < o @ 025). This order effect was evident in the other halves of these two groups, but it did not reach significant levels there. With groups treated as wholes, non-significant changes with time were observed in C and B. Group A behaved differ were obtained when the two factors, motor and social, on this scale were examined differentially. All correlations between these factors were positive, but they became closer as the experiment progressed (details available on request).
CoNcLusIons
Taking even this restricted group of patients, the aim of establishing clear cut differences between the drugs has not been achieved. The most clear cut finding was that no statistically significant difference was found between the ability of the two drugs, chlorpromazine and trifluoperazine, to improve motor activity in underactive schizophrenic patients. There were however, a number of observations which may be of interest. For the more active patients an overall measure of performance at the factory task showed an inconstantand non-significant initial improvement with both active drugs with maximum effect at the end of sixweeks.There after performance deteriorated, and when active drugs were reintroduced this deterioration was not reversed. The less active behaved differently. At the factory task they improved progressively through out the experiment, but the greatest increment in their performance occurred during the P1 phase. No group's speed of work was changed differentially by the two drugs. The least active group A increased theirspeed of work more during the sixweeks P1 phase than at any other time; Group B showed similar improvement during the P1 phase, but did not improve further when drugs were re introduced;
Group C showed virtually no change in speed ofwork during the three phases ofthe experi ment.
When on drugs there was a small but highly statistically significant improvement over pre-drug scores on the Venables scale, indicating that the two drugs were effective. No significant difference between drugs was found, and after the first six weeks of treatment the maximum response was reached, with some worsening thereafter.
There is a strong suggestion that the worsening in behaviour during the intervening placebo phase seen on the Venables scale occurs only in those previously treated with chlorpromazine. To this extent, therefore, trifluoperazine is to be preferred as a treatment. On this scale, as with the factory task, gains in behaviour obtained during the first six weeks of treatment were not repeated during the latter part of the cross-over. Strenuous attempts were made to maintain the environment constant for all groups, so that it is unlikely that chance environmental stimulation could be the sole explanation for these changes. A more likely explanation seems to be that, for the very inactive, once new patterns of behaviour have been initiated with the aid of drugs further improvement may occur without continuous medication. For the more active, however, starting drugs may also produce a temporary improvement, but the im provement is inconstant, it does not last as long and may be lost even when drugs are continued. Intermittent medication is evidently effective for inactive patients and may be advantageous. The more active seem to be improved to a much smaller extent by these drugs.
